Madison, AL, United States of America

Eric Thomas Healy

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Astrazeneca Ab, Nektar Therapeutics. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Thomas Healy. Retrieved from https://idiyas.com/inventor/eric-thomas-healy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Madison, AL (US) (2015)
  • Waltham, MA (US) (2015)

Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eric Thomas Healy: Innovator in Pharmaceutical Conjugates

Introduction

Eric Thomas Healy is a notable inventor based in Madison, AL (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug formulations. With a total of 2 patents, Healy's work focuses on enhancing the efficacy and delivery of medications.

Latest Patents

Healy's latest patents include the development of crystalline naloxol-PEG conjugates. These naloxol-polyethylene glycol conjugates are provided in oxalate or phosphate salt forms, including crystalline forms. The patents also detail methods for preparing these salt forms and pharmaceutical compositions that comprise them. This innovative approach aims to improve the therapeutic applications of naloxol.

Career Highlights

Throughout his career, Eric Thomas Healy has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Nektar Therapeutics. His experience in these organizations has allowed him to collaborate on various projects that advance drug development and delivery systems.

Collaborations

Healy has collaborated with esteemed professionals in his field, including Carl-Johan Aurell and Martin Hans Bohlin. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Eric Thomas Healy's contributions to pharmaceutical innovations, particularly in the area of naloxol-PEG conjugates, highlight his role as a significant inventor in the industry. His work continues to influence the development of effective drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…